Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Wen

Showing results (981-990 of 1,547) with videos related to

Pageof 155
Sort By:
Pediatric Blood & Cancer|April 30, 2013
Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working groupKatherine E Warren, Tina Y Poussaint, Gilbert Vezina, et al.
Neuro-Oncology|June 14, 2024
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastomaAndrew E Sloan, Kathryn Winter, Mark R Gilbert, et al.
NPJ Breast Cancer|July 21, 2025
Breast carcinomas associated with microglandular adenosis are linked to germline alterations in homologous recombination-deficiency genesChristopher J Schwartz, Iskender Genco, Matteo Repetto, et al.
The Journal of Nutrition, Health & Aging|December 15, 2022
Understanding the Complex Interactions between Coffee, Tea Intake and Neurologically Relevant Tissues Proteins in the Development of Anxiety and DepressionL Liu, B Cheng, J Ye, et al.
Histopathology|March 8, 2019
Micropapillary variant of mucinous carcinoma of the breast shows genetic alterations intermediate between those of mucinous carcinoma and micropapillary carcinomaFresia Pareja, Pier Selenica, David N Brown, et al.
Cancer Research|November 23, 2006
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entitiesElizabeth A Maher, Cameron Brennan, Patrick Y Wen, et al.
Cancer Research|June 25, 2009
A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patientsA Gregory Sorensen, Tracy T Batchelor, Wei-Ting Zhang, et al.
Research Square|June 30, 2025
Breast carcinomas associated with microglandular adenosis are linked to germline alterations in homologous recombination-deficiency genesChristopher J Schwartz, Iskender Genco, Matteo Repetto, et al.
Neuro-Oncology Advances|October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningiomaPriya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.
Neuro-Oncology|September 7, 2018
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challengesAlireza Mansouri, Laureen D Hachem, Sheila Mansouri, et al.
Pageof 155

Showing results (981-990 of 1,547) with videos related to

Sort By:
Pageof 155
Pediatric Blood & Cancer|April 30, 2013
Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working groupKatherine E Warren, Tina Y Poussaint, Gilbert Vezina, et al.
Neuro-Oncology|June 14, 2024
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastomaAndrew E Sloan, Kathryn Winter, Mark R Gilbert, et al.
NPJ Breast Cancer|July 21, 2025
Breast carcinomas associated with microglandular adenosis are linked to germline alterations in homologous recombination-deficiency genesChristopher J Schwartz, Iskender Genco, Matteo Repetto, et al.
The Journal of Nutrition, Health & Aging|December 15, 2022
Understanding the Complex Interactions between Coffee, Tea Intake and Neurologically Relevant Tissues Proteins in the Development of Anxiety and DepressionL Liu, B Cheng, J Ye, et al.
Histopathology|March 8, 2019
Micropapillary variant of mucinous carcinoma of the breast shows genetic alterations intermediate between those of mucinous carcinoma and micropapillary carcinomaFresia Pareja, Pier Selenica, David N Brown, et al.
Cancer Research|November 23, 2006
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entitiesElizabeth A Maher, Cameron Brennan, Patrick Y Wen, et al.
Cancer Research|June 25, 2009
A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patientsA Gregory Sorensen, Tracy T Batchelor, Wei-Ting Zhang, et al.
Research Square|June 30, 2025
Breast carcinomas associated with microglandular adenosis are linked to germline alterations in homologous recombination-deficiency genesChristopher J Schwartz, Iskender Genco, Matteo Repetto, et al.
Neuro-Oncology Advances|October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningiomaPriya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.
Neuro-Oncology|September 7, 2018
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challengesAlireza Mansouri, Laureen D Hachem, Sheila Mansouri, et al.
Pageof 155